Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 176

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Prefrontal dopamine signaling and cognitive symptoms of Parkinson’s disease

Open access
Narayanan, Nandakumar S., Rodnitzky, Robert L., Uc, Ergun Y.·2013·Reviews in the Neurosciences

Abstract

Cognitive dysfunction is a common symptom of Parkinson's disease (PD) that causes significant morbidity and mortality. The severity of these symptoms ranges from minor executive symptoms to frank dementia involving multiple domains. In the present review, we will concentrate on the aspects of cognitive impairment associated with prefrontal dopaminergic dysfunction, seen in non-demented patients with PD. These symptoms include executive dysfunction and disorders of thought, such as hallucinations and psychosis. Such symptoms may go on to predict dementia related to PD, which involves amnestic dysfunction and is typically seen later in the disease. Cognitive symptoms are associated with dysfunction in cholinergic circuits, in addition to the abnormalities in the prefrontal dopaminergic system. These circuits can be carefully studied and evaluated in PD, and could be leveraged to treat difficult clinical problems related to cognitive symptoms of PD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1515/revneuro-2013-0004

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Research works printed but not linked: 250

  1. Dopaminergic, 2006, Cools modulation of cognitive function - implications for treatment in Parkinson s disease, Neurosci Biobehav Rev, 30, 1, 10.1016/j.neubiorev.2005.03.024 · DOI · Paper page
  2. Voon, 2011, Impulse control disorders in Parkinson disease : a multicenter case control study, Neurol, 69
  3. Balzer, 2011, s disease dementia a longitudinal study, Parkinson Neuroepidemiology, 37
  4. Voon, 2006, de and Prospective prevalence of pathologic gambling and medication association in Parkinson disease, Neurology, 1750, 10.1212/01.wnl.0000218206.20920.4d · DOI · Paper page
  5. Rowan, 2007, Effects of donepezil on central processing speed and attentional measures in Parkinson s disease with dementia and dementia with Lewy bodies, Geriatr Cogn Disord, 23, 161, 10.1159/000098335 · DOI
  6. Huang, 2007, Carbon Metabolic brain networks associated with cognitive function in Parkinson s disease, Neuroimage, 714, 10.1016/j.neuroimage.2006.09.003 · DOI · Paper page
  7. Müller, 2006, The DONPAD - study treatment of dementia in patients with Parkinson s disease with donepezil, Neural Transm, 71, 27
  8. Pontone, 2006, Clinical features associated with impulse control disorders in Parkinson disease, Neurology, 67
  9. Hughes, 1992, Accuracy of clinical diagnosis of idiopathic Parkinson s disease : a clinico - pathological study of cases, Neurol Psychiatr, 181, 10.1136/jnnp.55.3.181 · DOI · Paper page
  10. Bohnen, 2003, Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease : an in vivo positron emission tomographic study, Arch, 1745
  11. Seamans, 1998, receptor modulation of hippocampal - prefrontal cortical circuits integrating spatial memory with executive functions in the rat, Neurosci, 18, 1, 10.1523/JNEUROSCI.18-04-01613.1998 · DOI · Paper page
  12. Scatton, 1983, Reduction of cortical dopamine noradrenaline serotonin and their metabolites in Parkinson s disease, Brain Res, 275
  13. Jellinger, 2009, critical evaluation of current staging of α - synuclein pathology in Lewy body disorders, Biochim Biophys Acta, 730, 10.1016/j.bbadis.2008.07.006 · DOI · Paper page
  14. Kim, 2012, Association of cognitive dysfunction with neurocirculatory abnormalities in early Parkinson disease, Neurology, 1323, 10.1212/WNL.0b013e31826c1acd · DOI
  15. Dalrymple, 2010, The well - suited screen for cognitive impairment in Parkinson disease, Neurology, 1717, 10.1212/WNL.0b013e3181fc29c9 · DOI · Paper page
  16. Pascual, 2008, and executive performance in Parkinson s disease : a randomized study, Int Soc, 14, 832
  17. Dias, 2006, Changing plans : neural correlates of executive control in monkey and human frontal, cortex Brain Res, 174
  18. Seong, 2012, receptor modulation of action potential firing in a subpopulation of layer pyramidal neurons in the prefrontal, cortex Neurosci, 1
  19. Jellinger, 2009, critical evaluation of current staging of α - synuclein pathology in Lewy body disorders, Biochim Biophys Acta, 730, 10.1016/j.bbadis.2008.07.006 · DOI · Paper page
  20. Okubo, 1997, Decreased prefrontal dopamine receptors in schizophrenia revealed by PET, Nature, 1
  21. Emre, 2007, Clinical diagnostic criteria for dementia associated with Parkinson s disease quiz, Soc, 22, 1689
  22. Morrison, 2004, Effects of levodopa on cognitive functioning in moderate - to - severe Parkinson s disease, Neural Transm, 111
  23. Dubois, 1987, - dependent cognitive deficits in Parkinson s disease, Ann Neurol, 22
  24. Bohnen, 2003, Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease : an in vivo positron emission tomographic study, Arch, 1745
  25. Gaspar, 1995, receptor gene expression in the rat frontal cellular localization in different classes of efferent neurons, cortex Eur J Neurosci, 1050, 10.1111/j.1460-9568.1995.tb01092.x · DOI · Paper page
  26. Gibb, 1988, The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson s disease, Neurol Psychiatr, 745, 10.1136/jnnp.51.6.745 · DOI · Paper page
  27. Aarsland, 2010, The epidemiology of dementia associated with Parkinson s disease, Brain Pathology, 20, 633, 10.1111/j.1750-3639.2009.00369.x · DOI · Paper page
  28. Weinberger, 1986, Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia Regional cerebral blood flow evidence, Arch Gen Psychiatry, 114, 10.1001/archpsyc.1986.01800020020004 · DOI · Paper page
  29. Meyer, 2009, Reduced α β - nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease, Arch Gen Psychiatry, 4, 866, 10.1001/archgenpsychiatry.2009.106 · DOI · Paper page
  30. Aarsland, 2002, Donepezil for cognitive impairment in Parkinson s disease : a randomised controlled study, Neurol Psychiatr, 708, 10.1136/jnnp.72.6.708 · DOI · Paper page
  31. Goldman, 1998, The cortical dopamine system role in memory, cognition Adv Pharmacol, 707
  32. Emre, 2007, Clinical diagnostic criteria for dementia associated with Parkinson s disease quiz, Soc, 22, 1689
  33. Nikiforuk, 2012, receptor modulation of set shifting : the role of stress exposure, Pharmacol, 23, 1
  34. Seamans, 1998, receptor modulation of hippocampal - prefrontal cortical circuits integrating spatial memory with executive functions in the rat, Neurosci, 18, 1, 10.1523/JNEUROSCI.18-04-01613.1998 · DOI · Paper page
  35. Javoy, 1981, Microtopography of tyrosine hydroxylase glutamic acid decarboxylase and choline acetyltransferase in the substantia nigra and ventral tegmental area of control and Parkinsonian brains, Neurochem, 37
  36. Arendt, 1983, Loss of neurons in the nucleus basalis of Meynert in Alzheimer s disease paralysis agitans and Korsakoff s Disease, Acta Neuropathol, 61
  37. Narayanan, 2012, dopamine signaling is required for temporal control, Proc Natl Acad Sci USA, 1
  38. Coull, 2011, neurochemical substrates of timing, Neuropsychopharmacology, 36, 10.1038/npp.2010.113 · DOI · Paper page
  39. Okubo, 1997, Decreased prefrontal dopamine receptors in schizophrenia revealed by PET, Nature, 1
  40. Miller, 2001, An integrative theory of prefrontal function, cortex Annu Rev Neurosci, 24, 167, 10.1146/annurev.neuro.24.1.167 · DOI · Paper page
  41. Candy, 1983, Pathological changes in the nucleus of Meynert in Alzheimer s and Parkinson s diseases, Neurol Sci, 59
  42. Kehm, 2012, a Pathological α - Synuclein Transmission Initiates Parkinson - like Neurodegeneration in Nontransgenic Mice, Science, 338
  43. Williams, 2008, Attentional control in Parkinson s disease is dependent on COMT val genotype, Brain, 158
  44. Garell, 2012, Functional connection between posterior superior temporal gyrus and ventrolateral prefrontal cortex in human Epub ahead of print, Cortex
  45. Müller, 2001, Delay of simple reaction time after levodopa intake, Clin Neurophysiol, 112
  46. Uc, 2009, Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort, Neurology, 73
  47. Wolk, 1992, Clozapine treatment of psychosis in Parkinson s disease : a report of five consecutive cases, Clin Psychiatry, 53
  48. Voon, 2006, de and a Prevalence of repetitive and reward - seeking behaviors in Parkinson disease, Neurology, 67
  49. Dubois, 1997, Cognitive deficits in Parkinson s disease, Neurol, 244
  50. Jahanshahi, 2010, Dopaminergic modulation of striato - frontal connectivity during motor timing in Parkinson s disease, Brain, 133
  51. Kempster, 2010, Relationships between age and late progression of Parkinson s disease : a clinico - pathological study, Brain, 133
  52. Crizzle, 2012, Parkinson disease driving an evidence based, review Neurology, 2067, 10.1212/WNL.0b013e3182749e95 · DOI
  53. Emre, 2004, for dementia associated with Parkinson s disease, Engl J Med, 351
  54. Kehm, 2012, Intracerebral inoculation of pathological α - synuclein initiates a rapidly progressive neurodegenerative α - synucleinopathy in mice, Exp Med, 209
  55. Jahanshahi, 2010, Dopaminergic modulation of striato - frontal connectivity during motor timing in Parkinson s disease, Brain, 133
  56. Levy, 2002, The association of incident dementia with mortality in, Neurology, 59
  57. Gaspar, 1995, receptor gene expression in the rat frontal cellular localization in different classes of efferent neurons, cortex Eur J Neurosci, 1050, 10.1111/j.1460-9568.1995.tb01092.x · DOI · Paper page
  58. Lange, 1992, dopa withdrawal in Parkinson s disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction, Psychopharmacology, 107
  59. Müller, 2006, The DONPAD - study treatment of dementia in patients with Parkinson s disease with donepezil, Neural Transm, 71, 27
  60. Pontone, 2006, Clinical features associated with impulse control disorders in Parkinson disease, Neurology, 67
  61. Narayanan, 2009, Delay activity in rodent frontal cortex during a simple reaction time task, Neurophysiol, 101
  62. Litvan, 2011, Task Force on mild cognitive impairment in Parkinson s disease critical of, review, 26, 1814
  63. Fabbrini, 2002, Donepezil in the treatment of hallucinations and delusions in Parkinson s disease, Sci, 23
  64. Cools, 2002, Dopaminergic modulation of high - level cognition in Parkinson s disease : the role of the prefrontal cortex revealed by PET, Brain, 125
  65. Litvan, 2011, Task Force on mild cognitive impairment in Parkinson s disease critical of, review, 26, 1814
  66. Aarsland, 2010, The epidemiology of dementia associated with Parkinson s disease, Brain Pathology, 20, 633, 10.1111/j.1750-3639.2009.00369.x · DOI · Paper page
  67. Swanberg, 2004, Executive dysfunction in Alzheimer disease, Arch, 556
  68. Fuster, 2008, The th ed New Academic, Prefrontal Cortex
  69. Lippa, 2007, boundary issues diagnosis treatment molecular, pathology biomarkers Neurology, 812
  70. Polito, 2012, Interaction of caudate dopamine depletion and brain metabolic changes with cognitive dysfunction in early Parkinson s disease, Aging, 206
  71. Bédard, 1999, Acute and long - term administration of anticholinergics in Parkinson s disease : specific effects on the subcortico - frontal syndrome, Brain, 289
  72. Baddeley, 1998, The central executive a concept and some misconceptions, Int Neuropsychol Soc, 523, 10.1017/S135561779800513X · DOI · Paper page
  73. Litvan, 1991, Differential memory and executive functions in demented patients with Parkinson s and Alzheimer s disease, Neurol Psychiatry, 54, 25, 10.1136/jnnp.54.1.25 · DOI
  74. Meyer, 2009, Reduced α β - nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease, Arch Gen Psychiatry, 4, 866, 10.1001/archgenpsychiatry.2009.106 · DOI · Paper page
  75. Voon, 2006, de and a Prevalence of repetitive and reward - seeking behaviors in Parkinson disease, Neurology, 67
  76. Westerink, 1998, The pharmacology of mesocortical dopamine neurons : a dual - probe microdialysis study in the ventral tegmental area and prefrontal cortex of the rat brain, Pharmacol Exp Ther, 285
  77. Gilman, 2010, Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes, Neurology, 1416, 10.1212/WNL.0b013e3181dc1a55 · DOI · Paper page
  78. Hobson, 2004, and incidence of dementia in a cohort of older subjects with Parkinson s disease in the United Kingdom, Risk, 19, 1043
  79. Kaasinen, 2001, Rinne Increased frontal fluorodopa uptake in early Parkinson s disease : sex differences in the prefrontal, cortex Brain, 18, 124
  80. Kehm, 2012, a Pathological α - Synuclein Transmission Initiates Parkinson - like Neurodegeneration in Nontransgenic Mice, Science, 338
  81. Dubois, 1997, Cognitive deficits in Parkinson s disease, Neurol, 244
  82. Narayanan, 2012, dopamine signaling is required for temporal control, Proc Natl Acad Sci USA, 1
  83. Compta, 2011, de and Alzheimer - type pathologies in Parkinson s disease dementia : which is more important, Brain, 134
  84. Foltynie, 2004, a The cognitive ability of an incident cohort of Parkinson s patients in the UK The CamPaIGN study, Brain, 127
  85. Williams, 2009, The distinct cognitive syndromes of Parkinson s disease year follow - up of the CamPaIGN cohort, Brain, 132
  86. Jellinger, 2011, deposition and non - motor symptoms in Parkinson disease, Neurol Sci, 310
  87. Floresco, 2001, Delay - dependent modulation of memory retrieval by infusion of a dopamine agonist into the rat medial prefrontal, cortex Neurosci, 1
  88. Floresco, 2001, Delay - dependent modulation of memory retrieval by infusion of a dopamine agonist into the rat medial prefrontal, cortex Neurosci, 1
  89. Rowan, 2007, Effects of donepezil on central processing speed and attentional measures in Parkinson s disease with dementia and dementia with Lewy bodies, Geriatr Cogn Disord, 23, 161, 10.1159/000098335 · DOI
  90. Rizzo, 2005, Visual dysfunction in Parkinson disease without dementia, Neurology, 1907
  91. Burton, 2004, Cerebral atrophy in Parkinson s disease with and without dementia : a comparison with Alzheimer s disease dementia with Lewy bodies and controls, Brain, 127
  92. Miller, 2001, An integrative theory of prefrontal function, cortex Annu Rev Neurosci, 24, 167, 10.1146/annurev.neuro.24.1.167 · DOI · Paper page
  93. Vrieze, 2013, Measuring extrastriatal dopamine release during a reward learning task, Hum Brain Mapp, 575, 10.1002/hbm.21456 · DOI
  94. Crizzle, 2012, Parkinson disease driving an evidence based, review Neurology, 2067, 10.1212/WNL.0b013e3182749e95 · DOI
  95. Lange, 1992, dopa withdrawal in Parkinson s disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction, Psychopharmacology, 107
  96. Claassen, 2010, Tippmann sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century, Neurology, 494, 10.1212/WNL.0b013e3181ec7fac · DOI · Paper page
  97. Fujita, 2006, Widespread decrease of nicotinic acetylcholine receptors in Parkinson s disease, Ann Neurol, 59
  98. Jellinger, 1999, Post mortem studies in Parkinson s disease is it possible to detect brain areas for specific symptoms, Neural Transm, 1
  99. Kieburtz, 1994, The effect of deprenyl and tocopherol on cognitive performance in early untreated Parkinson s disease Parkinson Study Group, Neurology, 1756, 10.1212/WNL.44.9.1756 · DOI
  100. Schmitt, 2010, Efficacy of rivastigmine on executive function in patients with Parkinson s disease dementia, Neurosci Ther, 16, 330, 10.1111/j.1755-5949.2010.00182.x · DOI
  101. Burack, 2010, In vivo amyloid imaging in autopsy - confirmed Parkinson disease with dementia, Neurology, 74
  102. Dirnberger, 2005, Executive dysfunction in Parkinson s disease is associated with altered pallidal - frontal processing, Neuroimage, 25, 588, 10.1016/j.neuroimage.2004.11.023 · DOI
  103. Cooper, 1991, Cognitive impairment in early untreated Parkinson s disease and its relationship to motor disability, Brain, 114
  104. Kempster, 2010, Relationships between age and late progression of Parkinson s disease : a clinico - pathological study, Brain, 133
  105. Wurtman, 2012, medicine strategies for managing patients with Parkinsonism and cognitive deficits Metab Clin Exp Available at http www ncbi nlm nih gov pubmed Accessed September, Personalized, 28
  106. Morrison, 2004, Effects of levodopa on cognitive functioning in moderate - to - severe Parkinson s disease, Neural Transm, 111
  107. Javoy, 1980, Is the mesocortical dopaminergic system involved in Parkinson disease, Neurology, 30, 1326, 10.1212/WNL.30.12.1326 · DOI · Paper page
  108. Sawamoto, 2008, Cognitive deficits and striato - frontal dopamine release in Parkinson s disease, Brain, 131
  109. Fabbrini, 2002, Donepezil in the treatment of hallucinations and delusions in Parkinson s disease, Sci, 23
  110. Jellinger, 1999, Post mortem studies in Parkinson s disease is it possible to detect brain areas for specific symptoms, Neural Transm, 1
  111. Williams, 2008, Attentional control in Parkinson s disease is dependent on COMT val genotype, Brain, 158
  112. Wurtman, 2012, medicine strategies for managing patients with Parkinsonism and cognitive deficits Metab Clin Exp Available at http www ncbi nlm nih gov pubmed Accessed September, Personalized, 28
  113. Asaad, 1998, Neural activity in the primate prefrontal cortex during associative learning, Neuron, 21, 1399, 10.1016/S0896-6273(00)80658-3 · DOI · Paper page
  114. Litvan, 1991, Differential memory and executive functions in demented patients with Parkinson s and Alzheimer s disease, Neurol Psychiatry, 54, 25, 10.1136/jnnp.54.1.25 · DOI
  115. Aarsland, 2005, systematic review of prevalence studies of dementia in Parkinson s disease, 20, 1255
  116. Dubois, 1987, - dependent cognitive deficits in Parkinson s disease, Ann Neurol, 22
  117. Scatton, 1983, Reduction of cortical dopamine noradrenaline serotonin and their metabolites in Parkinson s disease, Brain Res, 275
  118. Aarsland, 2005, systematic review of prevalence studies of dementia in Parkinson s disease, 20, 1255
  119. Dias, 2006, Changing plans : neural correlates of executive control in monkey and human frontal, cortex Brain Res, 174
  120. Elgh, 2009, Cognitive function in early Parkinson s disease : a population - based study, Eur J Neurol, 16, 1278, 10.1111/j.1468-1331.2009.02707.x · DOI · Paper page
  121. Narayanan, 2006, - down control of motor cortex ensembles by dorsomedial prefrontal, Top cortex Neuron, 921
  122. Voon, 2011, Impulse control disorders in Parkinson disease : a multicenter case control study, Neurol, 69
  123. Williams, 2007, of cognitive dysfunction in an incident Parkinson s disease cohort, Evolution Brain, 130
  124. Forsaa, 2010, a What predicts mortality in Parkinson disease a prospective population - based long - term study, Neurology, 1270, 10.1212/WNL.0b013e3181f61311 · DOI · Paper page
  125. Müller, 2001, Delay of simple reaction time after levodopa intake, Clin Neurophysiol, 112
  126. Graybiel, 1994, The basal ganglia and adaptive motor control, Science, 265
  127. Gilman, 2010, Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes, Neurology, 1416, 10.1212/WNL.0b013e3181dc1a55 · DOI · Paper page
  128. Asaad, 1998, Neural activity in the primate prefrontal cortex during associative learning, Neuron, 21, 1399, 10.1016/S0896-6273(00)80658-3 · DOI · Paper page
  129. Wu, 2012, The catechol methyltransferase Met polymorphism modulates fronto - cortical dopamine turnover in early Parkinson s disease : a PET study, Brain, 158
  130. Pascual, 2008, and executive performance in Parkinson s disease : a randomized study, Int Soc, 14, 832
  131. Braver, 1999, control in schizophrenia : a computational model of dopamine and prefrontal function, Cognition Biol Psychiatry, 312, 10.1016/S0006-3223(99)00116-X · DOI · Paper page
  132. Williams, 2007, of cognitive dysfunction in an incident Parkinson s disease cohort, Evolution Brain, 130
  133. Ávila, 2011, Impulsive and compulsive behaviors in Parkinson s disease : a one - year follow - up study, Neurol Sci, 310
  134. Weinberger, 1986, Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia Regional cerebral blood flow evidence, Arch Gen Psychiatry, 114, 10.1001/archpsyc.1986.01800020020004 · DOI · Paper page
  135. Dopaminergic, 2006, Cools modulation of cognitive function - implications for treatment in Parkinson s disease, Neurosci Biobehav Rev, 30, 1, 10.1016/j.neubiorev.2005.03.024 · DOI · Paper page
  136. Huang, 2007, Carbon Metabolic brain networks associated with cognitive function in Parkinson s disease, Neuroimage, 714, 10.1016/j.neuroimage.2006.09.003 · DOI · Paper page
  137. Ekman, 2012, Functional brain activity and presynaptic dopamine uptake in patients with Parkinson s disease and mild cognitive impairment : a cross - sectional study, Lancet Neurol, 11, 679, 10.1016/S1474-4422(12)70138-2 · DOI · Paper page
  138. Graybiel, 1994, The basal ganglia and adaptive motor control, Science, 265
  139. Esposito, 2011, Cools Inverted shaped dopamine actions on human working memory and cognitive control, Biol Psychiatry, 69
  140. Fuster, 2008, The th ed New Academic, Prefrontal Cortex
  141. Candy, 1983, Pathological changes in the nucleus of Meynert in Alzheimer s and Parkinson s diseases, Neurol Sci, 59
  142. Coull, 2011, neurochemical substrates of timing, Neuropsychopharmacology, 36, 10.1038/npp.2010.113 · DOI · Paper page
  143. Aarsland, 2000, Predictors of nursing home placement in Parkinson s disease : a population - based prospective study, Am Geriatr Soc, 938, 10.1111/j.1532-5415.2000.tb06891.x · DOI · Paper page
  144. Aarsland, 2011, Mild cognitive impairment in Parkinson s disease, Curr Neurol Neurosci Rep, 11, 371, 10.1007/s11910-011-0203-1 · DOI · Paper page
  145. Jellinger, 2011, deposition and non - motor symptoms in Parkinson disease, Neurol Sci, 310
  146. Seong, 2012, receptor modulation of action potential firing in a subpopulation of layer pyramidal neurons in the prefrontal, cortex Neurosci, 1
  147. Kaasinen, 2001, Rinne Increased frontal fluorodopa uptake in early Parkinson s disease : sex differences in the prefrontal, cortex Brain, 18, 124
  148. Voon, 2006, de and Prospective prevalence of pathologic gambling and medication association in Parkinson disease, Neurology, 1750, 10.1212/01.wnl.0000218206.20920.4d · DOI · Paper page
  149. Fonnum, 1966, Is choline acetyltransferase present in synaptic vesicles, Biochem Pharmacol, 15, 1641, 10.1016/0006-2952(66)90216-4 · doi:10.1016/0006-2952(66)90216-4
  150. Vrieze, 2013, Measuring extrastriatal dopamine release during a reward learning task, Hum Brain Mapp, 575, 10.1002/hbm.21456 · DOI
  151. Westerink, 1998, The pharmacology of mesocortical dopamine neurons : a dual - probe microdialysis study in the ventral tegmental area and prefrontal cortex of the rat brain, Pharmacol Exp Ther, 285
  152. Castner, 2007, Tuning the engine of a focus on receptor interactions in prefrontal, cognition cortex Brain, 1
  153. Perry, 1985, Cholinergic correlates of cognitive impairment in Parkinson s disease : comparisons with Alzheimer s disease, Neurol Psychiatr, 413, 10.1136/jnnp.48.5.413 · DOI · Paper page
  154. Rakshi, 1999, Frontal midbrain and striatal dopaminergic function in early and advanced Parkinson s disease dopa - PET study, Brain, 18, 122
  155. Irwin, 2012, substrates of Parkinson disease dementia, Neurol, 587
  156. Elgh, 2009, Cognitive function in early Parkinson s disease : a population - based study, Eur J Neurol, 16, 1278, 10.1111/j.1468-1331.2009.02707.x · DOI · Paper page
  157. Compta, 2011, de and Alzheimer - type pathologies in Parkinson s disease dementia : which is more important, Brain, 134
  158. Fahn, 2004, the progression of Parkinson s disease, Engl J Med, 351
  159. Schmitt, 2010, Efficacy of rivastigmine on executive function in patients with Parkinson s disease dementia, Neurosci Ther, 16, 330, 10.1111/j.1755-5949.2010.00182.x · DOI
  160. Dunning, 2012, Can Parkinson s disease pathology be propagated from one neuron to another, Prog Neurobiol, 205, 10.1016/j.pneurobio.2011.11.003 · DOI
  161. Castner, 2007, Tuning the engine of a focus on receptor interactions in prefrontal, cognition cortex Brain, 1
  162. Sawamoto, 2008, Cognitive deficits and striato - frontal dopamine release in Parkinson s disease, Brain, 131
  163. Burack, 2010, In vivo amyloid imaging in autopsy - confirmed Parkinson disease with dementia, Neurology, 74
  164. Rizzo, 2005, Visual dysfunction in Parkinson disease without dementia, Neurology, 1907
  165. Factor, 2003, Longitudinal outcome of Parkinson s disease patients with psychosis, Neurology, 1756, 10.1212/01.WNL.0000068010.82167.CF · DOI · Paper page
  166. Swanberg, 2004, Executive dysfunction in Alzheimer disease, Arch, 556
  167. Cooper, 1991, Cognitive impairment in early untreated Parkinson s disease and its relationship to motor disability, Brain, 114
  168. Cools, 2002, Dopaminergic modulation of high - level cognition in Parkinson s disease : the role of the prefrontal cortex revealed by PET, Brain, 125
  169. Dubois, 1995, Do cognitive changes of Parkinson s disease result from dopamine depletion, Neural Transm, 45, 27
  170. Dunning, 2012, Can Parkinson s disease pathology be propagated from one neuron to another, Prog Neurobiol, 205, 10.1016/j.pneurobio.2011.11.003 · DOI
  171. Phillips, 2004, Magnitude of dopamine release in medial prefrontal cortex predicts accuracy of memory on a delayed response task, Neurosci, 24, 547, 10.1523/JNEUROSCI.4653-03.2004 · DOI · Paper page
  172. Gotham, 1988, Frontal cognitive function in patients with Parkinson s disease on and off levodopa, Brain, 111
  173. Phillips, 2004, Magnitude of dopamine release in medial prefrontal cortex predicts accuracy of memory on a delayed response task, Neurosci, 24, 547, 10.1523/JNEUROSCI.4653-03.2004 · DOI · Paper page
  174. Garell, 2012, Functional connection between posterior superior temporal gyrus and ventrolateral prefrontal cortex in human Epub ahead of print, Cortex
  175. Kotzbauer, 2012, Perlmutter Pathologic accumulation of α - synuclein and Aβ in Parkinson disease patients with dementia, Arch, 10, 1
  176. Balzer, 2011, s disease dementia a longitudinal study, Parkinson Neuroepidemiology, 37
  177. Arendt, 1983, Loss of neurons in the nucleus basalis of Meynert in Alzheimer s disease paralysis agitans and Korsakoff s Disease, Acta Neuropathol, 61
  178. McKeith, 1996, Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies report of the consortium on DLB international workshop, Neurology, 1113, 10.1212/WNL.47.5.1113 · DOI · Paper page
  179. Bosboom, 2003, The role of acetylcholine and dopamine in dementia and psychosis in Parkinson s disease, Neural Transm, 185
  180. Hughes, 1992, Accuracy of clinical diagnosis of idiopathic Parkinson s disease : a clinico - pathological study of cases, Neurol Psychiatr, 181, 10.1136/jnnp.55.3.181 · DOI · Paper page
  181. Williams, 2009, The distinct cognitive syndromes of Parkinson s disease year follow - up of the CamPaIGN cohort, Brain, 132
  182. Fahn, 2004, the progression of Parkinson s disease, Engl J Med, 351
  183. Kim, 2012, Association of cognitive dysfunction with neurocirculatory abnormalities in early Parkinson disease, Neurology, 1323, 10.1212/WNL.0b013e31826c1acd · DOI
  184. Javoy, 1980, Is the mesocortical dopaminergic system involved in Parkinson disease, Neurology, 30, 1326, 10.1212/WNL.30.12.1326 · DOI · Paper page
  185. Dubois, 1995, Do cognitive changes of Parkinson s disease result from dopamine depletion, Neural Transm, 45, 27
  186. Ekman, 2012, Functional brain activity and presynaptic dopamine uptake in patients with Parkinson s disease and mild cognitive impairment : a cross - sectional study, Lancet Neurol, 11, 679, 10.1016/S1474-4422(12)70138-2 · DOI · Paper page
  187. Wolk, 1992, Clozapine treatment of psychosis in Parkinson s disease : a report of five consecutive cases, Clin Psychiatry, 53
  188. Kotzbauer, 2012, Perlmutter Pathologic accumulation of α - synuclein and Aβ in Parkinson disease patients with dementia, Arch, 10, 1
  189. Polito, 2012, Interaction of caudate dopamine depletion and brain metabolic changes with cognitive dysfunction in early Parkinson s disease, Aging, 206
  190. Burton, 2004, Cerebral atrophy in Parkinson s disease with and without dementia : a comparison with Alzheimer s disease dementia with Lewy bodies and controls, Brain, 127
  191. Ávila, 2011, Impulsive and compulsive behaviors in Parkinson s disease : a one - year follow - up study, Neurol Sci, 310
  192. Muslimovic, 2005, Post Speelman Schmand Cognitive profile of patients with newly diagnosed Parkinson disease, Neurology, 1239, 10.1212/01.wnl.0000180516.69442.95 · DOI · Paper page
  193. Arnsten, 2005, of executive functions : catecholamine influences on prefrontal cortical functions, Neurobiology Biol Psychiatry, 1377, 10.1016/j.biopsych.2004.08.019 · DOI · Paper page
  194. Weintraub, 2006, Association of dopamine agonist use with impulse control disorders in Parkinson disease, Arch, 969
  195. Bohnen, 2006, Cognitive correlates of cortical cholinergic denervation in Parkinson s disease and parkinsonian dementia, Neurol, 253
  196. Braver, 1999, control in schizophrenia : a computational model of dopamine and prefrontal function, Cognition Biol Psychiatry, 312, 10.1016/S0006-3223(99)00116-X · DOI · Paper page
  197. Williams, 2006, Cognitive deficits and psychosis in Parkinson s disease a review of pathophysiology and therapeutic options, CNS Drugs, 20, 477, 10.2165/00023210-200620060-00004 · DOI · Paper page
  198. Lennox, 1992, body dementia, Clin, 1
  199. Williams, 1995, Modulation of memory fields by dopamine receptors in prefrontal, cortex Nature, 1
  200. Dymecki, 1996, Changes in dopaminergic neurons of the mesocorticolimbic system in Parkinson s disease, Folia Neuropathol, 102

200 of 250 shown

Cited by

See all 176

Metadata

Authors
Narayanan, N. S., Rodnitzky, R. L., & Uc, E. Y.
Venue
Reviews in the Neurosciences
Published
2013-01-01
Volume
24
Issue
3
Pages
267-78
ISSN
  • 0334-1763 (ISSN-L)
  • 2191-0200
OpenAlex
W2024403313
Cited by
176
References
24
FWCI
8.55
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prefrontal dopamine signaling and cognitive symptoms of Parkinson’s disease. https://app.cochat.ai/papers/10.1515/revneuro-2013-0004
The paper
Narayanan, N. S., Rodnitzky, R. L., & Uc, E. Y. (2013). Prefrontal dopamine signaling and cognitive symptoms of Parkinson’s disease. Reviews in the Neurosciences. https://doi.org/10.1515/revneuro-2013-0004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.